IGF2 DMR0 Methylation, Loss of Imprinting, and Patient Prognosis in Esophageal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

IGF2 DMR0 Methylation, Loss of Imprinting, and Patient Prognosis in Esophageal Squamous Cell Carcinoma

Published:2013-12-07 Issue:4 Volume:21 Page:1166-1174
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Murata Asuka,Baba Yoshifumi,Watanabe Masayuki,Shigaki Hironobu,Miyake Keisuke,Ishimoto Takatsugu,Iwatsuki Masaaki,Iwagami Shiro,Yoshida Naoya,Oki Eiji,Morita Masaru,Nakao Mitsuyoshi,Baba Hideo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-013-3414-7.pdf

Reference47 articles.

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241–52.

2. Gertler R, Stein HJ, Langer R, et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Ann Surg. 2011;253:689–98.

3. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46–50.

4. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062–7.

5. Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut. 2004;53:925–30.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of imprinting genes’ loss of imprints in cancers and their clinical implications;Frontiers in Oncology;2024-05-15

2. Epigenetic and Genetics Factors;Molecular Targets and Cancer Therapeutics (Part 1);2023-04-18

3. Development of a prognostic nomogram based on an eight-gene signature for esophageal squamous cell carcinoma by weighted gene co-expression network analysis (WGCNA);Annals of Translational Medicine;2022-01

4. Epigenetics and therapeutic targets in gastrointestinal malignancies;Drug Discovery Today;2021-10

5. Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma;Current Pharmacology Reports;2020-09-12